{"id":1024,"date":"2025-12-07T19:30:21","date_gmt":"2025-12-07T19:30:21","guid":{"rendered":"http:\/\/elmoustkbal.com\/?p=1024"},"modified":"2025-12-07T19:30:21","modified_gmt":"2025-12-07T19:30:21","slug":"100-l-of-a-patient-serum-pool-n3-containing-fel-d-1-specific-ige-fel-d-1-negative-serum-or-tbs-as-negative-control-was-added-with-shaking-at-100-rpm-for-2-h-at-37c","status":"publish","type":"post","link":"https:\/\/elmoustkbal.com\/?p=1024","title":{"rendered":"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C"},"content":{"rendered":"<p>\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C. using IgE-antibodies from cat allergic patients for phage enrichment. Four candidates were isolated, displaying similar or lower IgE binding, reduced anaphylactic activity as measured by their capacity to stimulate basophil degranulation and, importantly, a significantly lower T cell reactivity in lymphoproliferative assays compared to the initial rFel d 1. In addition, all mutants showed ability to induce blocking antibodies in immunized mice.The approach presented here provides a straightforward procedure to generate a novel type of allergy vaccines for safer and efficacious treatment of allergic patients. == Introduction == The domestic cat (Felis domesticus) <a href=\"https:\/\/www.adooq.com\/nifurtimox.html\">Nifurtimox<\/a> is one of the most frequent domestic pets and approximately 10% of the general populace in industrialized countries is usually sensitized to cat allergens[1]. The <a href=\"http:\/\/ville-castelnaudary.eu\/fr\/multipage.xml?pg=1&#038;id=134662\">Rabbit Polyclonal to EPHB1<\/a> symptoms deriving from cat allergy manifest mainly as rhinoconjunctivitis with a strong tendency to progress to asthma, especially in children[2]. Exposure to cat allergen is a result of the natural behavior of the cat to lick and groom. Proteins of the saliva is usually left to dry and spread as small airborne particles[3]where it can be detected in a variety of indoor environments[4],[5]. The major allergen of the cat, formally termed Fel d 1, is a hetero-dimer member of the secretoglobin protein family[6],[7]found in skin, lachrymal glands and in particular in the saliva. More than 95% of cat allergic patients show elevated serum IgE levels to Fel d 1 which is, therefore, the primary target for the development of immunotherapeutic vaccines for the treatment of cat allergy[8],[9]. Allergen-specific IgE is the important molecule for the development of allergic symptoms. The synthesis of IgE requires a B cell to undergo class switch recombination in close contact with allergen-specific T helper 2 cells (Th2)[10]. The T cell receptor on primed CD4+ T cells recognize antigen presenting cells transporting MHC II molecules with tightly bound enzyme-digested linear polypeptides of 12 to 25 Nifurtimox amino acids derived from the primary structure of the antigen[11]. B cells expressing allergen-specific IgE as a part of the B cell receptor (BCR) identify the surface structures of the allergens. After allergen binding, the receptor-antigen complex is usually internalized, the antigen processed, and displayed as peptide-MHC II complex around the B cell surface[12]. These processes link the 3D structure of the allergen to the linear peptides offered to the T cell receptor by the MHC class II complex. Allergen-activated T cells are responsible for late-phase reactions (LPR), occurring 68 hours after allergen challenge eliciting symptoms ranging from oedema and itching to eczema, and also play a prominent and pivotal role in the pathogenesis of allergic asthma[13]as shown by the elevated numbers of CD4+T cells found in bronchial mucosa, BAL fluid, and sputum in these patients. The most common treatment of Nifurtimox allergic diseases is usually either alleviation of symptoms using drugs or advice the patient to avoid the allergen source[14],[15]. However, allergen-specific immunotherapy (SIT), is the only treatment able to cure allergic diseases[16]. Successful SIT is usually thought to take action through tolerance Nifurtimox mechanisms induced by regulatory T cells and blocking IgG antibodies[17]. Induction of IgG antibodies may reduce clinical symptoms in several ways, by competition with IgE for binding epitopes around the allergens[18],[19], by inhibition of IgE-facilitated antigen presentation to CD4+T cells[20], but also by interference with mast cell degranulation by down-regulation of IgE receptors signaling via inhibitory motifs around the FcRIIb receptor[21]. Numerous studies have shown that crude allergen extracts currently used in SIT are clinically effective[22],.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-1024","post","type-post","status-publish","format-standard","hentry","category-igf-receptors"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C - DHFR inhibitors in non-small cell lung cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/elmoustkbal.com\/?p=1024\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C - DHFR inhibitors in non-small cell lung cancer\" \/>\n<meta property=\"og:description\" content=\"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/elmoustkbal.com\/?p=1024\" \/>\n<meta property=\"og:site_name\" content=\"DHFR inhibitors in non-small cell lung cancer\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-07T19:30:21+00:00\" \/>\n<meta name=\"author\" content=\"webmaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"webmaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1024#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1024\"},\"author\":{\"name\":\"webmaster\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#\\\/schema\\\/person\\\/6ba91697c07f5b1e48a1c50fec2fd4a0\"},\"headline\":\"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C\",\"datePublished\":\"2025-12-07T19:30:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1024\"},\"wordCount\":631,\"articleSection\":[\"IGF Receptors\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1024\",\"url\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1024\",\"name\":\"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C - DHFR inhibitors in non-small cell lung cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#website\"},\"datePublished\":\"2025-12-07T19:30:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#\\\/schema\\\/person\\\/6ba91697c07f5b1e48a1c50fec2fd4a0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1024#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/elmoustkbal.com\\\/?p=1024\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1024#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/elmoustkbal.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#website\",\"url\":\"https:\\\/\\\/elmoustkbal.com\\\/\",\"name\":\"DHFR inhibitors in non-small cell lung cancer\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/elmoustkbal.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#\\\/schema\\\/person\\\/6ba91697c07f5b1e48a1c50fec2fd4a0\",\"name\":\"webmaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g\",\"caption\":\"webmaster\"},\"sameAs\":[\"http:\\\/\\\/elmoustkbal.com\"],\"url\":\"https:\\\/\\\/elmoustkbal.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C - DHFR inhibitors in non-small cell lung cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/elmoustkbal.com\/?p=1024","og_locale":"en_US","og_type":"article","og_title":"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C - DHFR inhibitors in non-small cell lung cancer","og_description":"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added&hellip;","og_url":"https:\/\/elmoustkbal.com\/?p=1024","og_site_name":"DHFR inhibitors in non-small cell lung cancer","article_published_time":"2025-12-07T19:30:21+00:00","author":"webmaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"webmaster","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/elmoustkbal.com\/?p=1024#article","isPartOf":{"@id":"https:\/\/elmoustkbal.com\/?p=1024"},"author":{"name":"webmaster","@id":"https:\/\/elmoustkbal.com\/#\/schema\/person\/6ba91697c07f5b1e48a1c50fec2fd4a0"},"headline":"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C","datePublished":"2025-12-07T19:30:21+00:00","mainEntityOfPage":{"@id":"https:\/\/elmoustkbal.com\/?p=1024"},"wordCount":631,"articleSection":["IGF Receptors"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/elmoustkbal.com\/?p=1024","url":"https:\/\/elmoustkbal.com\/?p=1024","name":"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C - DHFR inhibitors in non-small cell lung cancer","isPartOf":{"@id":"https:\/\/elmoustkbal.com\/#website"},"datePublished":"2025-12-07T19:30:21+00:00","author":{"@id":"https:\/\/elmoustkbal.com\/#\/schema\/person\/6ba91697c07f5b1e48a1c50fec2fd4a0"},"breadcrumb":{"@id":"https:\/\/elmoustkbal.com\/?p=1024#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/elmoustkbal.com\/?p=1024"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/elmoustkbal.com\/?p=1024#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/elmoustkbal.com\/"},{"@type":"ListItem","position":2,"name":"\ufeff100 l of a patient serum pool (n=3) containing Fel d 1-specific IgE, Fel d 1 negative serum, or TBS as negative control was added with shaking at 100 rpm for 2 h at 37C"}]},{"@type":"WebSite","@id":"https:\/\/elmoustkbal.com\/#website","url":"https:\/\/elmoustkbal.com\/","name":"DHFR inhibitors in non-small cell lung cancer","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/elmoustkbal.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/elmoustkbal.com\/#\/schema\/person\/6ba91697c07f5b1e48a1c50fec2fd4a0","name":"webmaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g","caption":"webmaster"},"sameAs":["http:\/\/elmoustkbal.com"],"url":"https:\/\/elmoustkbal.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/posts\/1024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1024"}],"version-history":[{"count":1,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/posts\/1024\/revisions"}],"predecessor-version":[{"id":1025,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/posts\/1024\/revisions\/1025"}],"wp:attachment":[{"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}